metipranolol
Sign in to saveAlso known as TUR695, BM-01004, VUAB-6453, VUAB6453, (+-)-metipranolol, acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester
Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.
Research
323 papers- Metipranolol.2006
- Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.Drugs · 1988
- Metipranolol promotes structure and function of retinal photoreceptors in the rd10 mouse model of human retinitis pigmentosa.Journal of neurochemistry · 2019
- Metipranolol-associated granulomatous anterior uveitis.The British journal of ophthalmology · 1991
- Drug-induced uveitis.Expert opinion on drug safety · 2015
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
{{Drugbox | verifiedrevid = 411547542 | IUPAC_name = (RS)-4-{[-2-hydroxy-3-(isopropylamino)propyl]oxy}-2,3,6-trimethylphenyl acetate | image = Metipranolol.svg | image_class = skin-invert-image | width = 200 | chirality = Racemic mixture
| tradename = Optipranolol | Drugs.com = | MedlinePlus = a601078 | pregnancy_category = | legal_status = | routes_of_administration =
Excerpted from Wikipedia’s “metipranolol” article, available under the CC BY-SA 4.0 licence.
Available in 9 languages
via Wikidata sitelinks · CC0